BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7897214)

  • 1. The NKB1 and HP-3E4 NK cells receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules.
    Lanier LL; Gumperz JE; Parham P; Melero I; López-Botet M; Phillips JH
    J Immunol; 1995 Apr; 154(7):3320-7. PubMed ID: 7897214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells.
    Kurago ZB; Lutz CT; Smith KD; Colonna M
    J Immunol; 1998 Feb; 160(4):1573-80. PubMed ID: 9469412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
    Bakker AB; Phillips JH; Figdor CG; Lanier LL
    J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK cell recognition of major histocompatibility complex class I molecules.
    Lanier LL; Phillips JH
    Semin Immunol; 1995 Apr; 7(2):75-82. PubMed ID: 7579197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes.
    D'Andrea A; Chang C; Franz-Bacon K; McClanahan T; Phillips JH; Lanier LL
    J Immunol; 1995 Sep; 155(5):2306-10. PubMed ID: 7650366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules.
    Litwin V; Gumperz J; Parham P; Phillips JH; Lanier LL
    J Exp Med; 1994 Aug; 180(2):537-43. PubMed ID: 8046332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
    Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell recognition of HLA class I molecules.
    Brooks AG; Boyington JC; Sun PD
    Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors.
    Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK
    J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor.
    Gumperz JE; Barber LD; Valiante NM; Percival L; Phillips JH; Lanier LL; Parham P
    J Immunol; 1997 Jun; 158(11):5237-41. PubMed ID: 9164941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
    Avril T; Jarousseau AC; Watier H; Boucraut J; Le Bouteiller P; Bardos P; Thibault G
    J Immunol; 1999 May; 162(10):5902-9. PubMed ID: 10229826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.
    Pérez-Villar JJ; Melero I; Navarro F; Carretero M; Bellón T; Llano M; Colonna M; Geraghty DE; López-Botet M
    J Immunol; 1997 Jun; 158(12):5736-43. PubMed ID: 9190923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of two anti-class I HLA monoclonal antibodies that block class I recognition by the NKB1 killer cell inhibitory receptor.
    Gumperz JE; Paterson JC; Litwin V; Valiante N; Lanier LL; Parham P; Little AM
    Tissue Antigens; 1996 Oct; 48(4 Pt 1):278-84. PubMed ID: 8946681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-Cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells.
    Seebach JD; Comrack C; Germana S; LeGuern C; Sachs DH; DerSimonian H
    J Immunol; 1997 Oct; 159(7):3655-61. PubMed ID: 9317166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic activity of natural killer cells lacking killer-inhibitory receptors for self-HLA class I molecules against autologous hematopoietic stem cells in healthy individuals.
    Grau R; Lang KS; Wernet D; Lang P; Niethammer D; Pusch CM; Handgretinger R
    Exp Mol Pathol; 2004 Apr; 76(2):90-8. PubMed ID: 15010286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptors for HLA class I molecules in human NK cells.
    Bottino C; Vitale M; Pende D; Biassoni R; Moretta A
    Semin Immunol; 1995 Apr; 7(2):67-73. PubMed ID: 7579196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cells lyse autologous herpes simplex virus infected targets using cytolytic mechanisms distributed clonotypically.
    Pietra G; Semino C; Cagnoni F; Boni L; Cangemi G; Frumento G; Melioli G
    J Med Virol; 2000 Nov; 62(3):354-63. PubMed ID: 11055246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative signalling via the P58/NKR for HLA.C alleles.
    Vitale M; Sivori S; Sanseverino L; Barbaresi M; Morelli L; Olcese L; Agugliano R; Bottino C; Moretta A
    Eur J Histochem; 1994; 38 Suppl 1():69-76. PubMed ID: 8547713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.
    Gumperz JE; Litwin V; Phillips JH; Lanier LL; Parham P
    J Exp Med; 1995 Mar; 181(3):1133-44. PubMed ID: 7532677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.